Evidence map›Paper›PMID 19116360›Full record

ArticleJournal of clinical microbiology2009

Failure of cloxacillin in treatment of a patient with borderline oxacillin-resistant Staphylococcus aureus endocarditis.

Stuart Skinner, Melanie Murray, Tom Walus, James A Karlowsky

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Borderline Oxacillin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Genetic and Phenotypic Changes Related to the Development ofAntibiotics (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Case Commentary: The hidden side of oxacillin resistance inAntimicrobial agents and chemotherapy · 2023
    Article
  9. Failure ofAntimicrobial agents and chemotherapy · 2023
    Article
  10. Article
  11. Mutations in theMicrobial genomics · 2021
    Article
  12. Hospital transmission of borderline oxacillin-resistantJournal of medical microbiology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Antimicrobial Resistance in ESKAPE Pathogens.Clinical microbiology reviews · 2020
    Review
  17. Review
  18. Dissemination Of t437-SCCInfection and drug resistance · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Stuart SkinnerDepartment of Medicine, Division of Infectious Diseases, University of Saskatchewan, Saskatoon S7N 0W8, Saskatchewan, Canada. stuart.skinner@saskatoonhealthregion.ca
Melanie Murray
Tom Walus
James A Karlowsky
Diagnostic Services Manitoba · CAHealth Sciences Centre · CAUniversity of British Columbia · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical evidence for failure with beta-lactam therapy has been lacking for patients with borderline oxacillin-resistant Staphylococcus aureus (BORSA) infections. We describe a failure of cloxacillin for a patient with endocarditis due to BORSA. The isolate also had false-negative thermonuclease and coagulase test results.

Indexed as

Drug Resistance, BacterialAdultAnti-Bacterial AgentsCloxacillinCoagulaseEndocarditis, BacterialHumansMicrococcal NucleaseOxacillinStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsCloxacillinCoagulaseMicrococcal NucleaseOxacillin

Identifiers

PMID19116360
PMCPMC2650896
OpenAlexW2158495949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.